Xponance’s Terns Pharmaceuticals TERN Stock Holding History

Xponance’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,709	Closed	-$459K	–	1877
2026 Q1	$459K	Buy	8,709 +2,032	+30%	+$83.5K	﹤0.01%	1056
2025 Q4	$270K	Buy	+6,677	New	+$154K	﹤0.01%	1234

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Xponance's TERN Position: Q2 2026 in Review

Xponance sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 8,709 shares — an estimated $459K sold.

Xponance first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $459K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Xponance reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Xponance sold 8,709 Terns Pharmaceuticals shares in Q2 2026, an estimated $459K.
Xponance first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Xponance's Terns Pharmaceuticals position peaked at $459K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.